Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.400
+0.050 (2.13%)
At close: Mar 20, 2026, 4:00 PM EDT
2.300
-0.100 (-4.17%)
After-hours: Mar 20, 2026, 7:37 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $5.5 million as of March 20, 2026. Its market cap has increased by 23.78% in one year.
Market Cap
5.50M
Enterprise Value
-1.65M
1-Year Change
23.78%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $5.50M, a decrease of -98.30%. That is a compound annual growth rate of -61.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 5.39M | 282.11% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 6.24M |
| Processa Pharmaceuticals | 6.17M |
| Moolec Science | 5.95M |
| Immuron | 5.74M |
| Liminatus Pharma | 5.74M |
| Mustang Bio | 5.71M |
| XTL Biopharmaceuticals | 5.20M |
| Silo Pharma | 4.79M |